Cargando…
The First Live-Cell Based Product in The Iranian Drug List; ReColorCell®
Vitiligo is an autoimmune skin disorder that can significantly affect the quality of life in patients. However, current treatment strategies such as phototherapy, topical glucocorticosteroids, or systemic immunosuppressants can be helpful in vitiligo management, and treatments for disease stability...
Autores principales: | Shahrbaf, Mohammad Amin, Ataei Fashtami, Leila, Vosough, Massoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105295/ https://www.ncbi.nlm.nih.gov/pubmed/37038701 http://dx.doi.org/10.22074/CELLJ.2023.1978336.1183 |
Ejemplares similares
-
Extraembryonic Mesenchymal Stromal/Stem Cells in Liver Diseases: A Critical Revision of Promising Advanced Therapy Medicinal Products
por: Shahrbaf, Mohammad Amin, et al.
Publicado: (2022) -
Hypertension in COVID-19, A Risk Factor for Infection or
A Late Consequence?
por: Barekat, Maryam, et al.
Publicado: (2022) -
Advanced Therapy Medicinal Products in Vitiligo; Current Status,
Future Prospect, and Approved Treatments
por: Ghashghaei, Shahriar, et al.
Publicado: (2023) -
Commentary: “To list, or not to list? That is the question”
por: Chen, Jing Yu, et al.
Publicado: (2021) -
The Prevalence of Hypertension and Obesity in Iranian Professional Drivers
por: Nikpajouh, Akbar, et al.
Publicado: (2023)